SHEPHERD KAPLAN KROCHUK, LLC - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 36 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SHEPHERD KAPLAN KROCHUK, LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$262,000
+175.8%
129,420
+317.5%
0.03%
+209.1%
Q1 2014$95,00031,0000.01%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 1,942,184$3,865,0004.53%
NEA Management Company, LLC 2,086,755$4,153,0000.20%
BVF INC/IL 150,000$299,0000.05%
ABNER HERRMAN & BROCK LLC 20,000$40,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$273,0000.01%
Spark Investment Management LLC 16,100$32,0000.01%
CSS LLC/IL 20,420$41,0000.00%
Waverly Advisors, LLC 2,670$5,0000.00%
PANAGORA ASSET MANAGEMENT INC 134,293$267,0000.00%
DIMENSIONAL FUND ADVISORS LP 466,573$928,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders